Literature DB >> 17502338

Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells.

Whitney S Helms1, Jerry L Jeffrey, Derek A Holmes, Michael B Townsend, Neil A Clipstone, Lishan Su.   

Abstract

We have reported previously that p115Rho guanine nucleotide exchange factor, its upstream activator Galpha13, and its effector RhoA are able to inhibit HIV-1 replication. Here, we show that RhoA is able to inhibit HIV-1 gene expression through the NFAT-binding site in the HIV long-terminal repeat. Constitutively active NFAT counteracts the inhibitory activity of RhoA, and inhibition of NFAT activation also inhibits HIV-1 gene expression. We have shown further that RhoA inhibits NFAT-dependent transcription and IL-2 production in human T cells. RhoA does not inhibit nuclear localization of NFAT but rather, inhibits its transcriptional activity. In addition, RhoA decreases the level of acetylated histone H3, but not NFAT occupancy, at the IL-2 promoter. These data suggest that activation of RhoA can modulate IL-2 gene expression by inhibiting the transcriptional activity of NFAT and chromatin structure at the IL-2 promoter during T cell activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502338      PMCID: PMC4418492          DOI: 10.1189/jlb.0206120

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  50 in total

1.  Modulation of HIV-1 replication by a novel RhoA effector activity.

Authors:  L Wang; H Zhang; P A Solski; M J Hart; C J Der; L Su
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein.

Authors:  M Iacobelli; W Wachsman; K L McGuire
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

Review 3.  Leukocyte transendothelial migration: orchestrating the underlying molecular machinery.

Authors:  R A Worthylake; K Burridge
Journal:  Curr Opin Cell Biol       Date:  2001-10       Impact factor: 8.382

Review 4.  Partners in transcription: NFAT and AP-1.

Authors:  F Macián; C López-Rodríguez; A Rao
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

5.  Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization.

Authors:  C M Porter; M A Havens; N A Clipstone
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 6.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

7.  Expression cloning of lsc, a novel oncogene with structural similarities to the Dbl family of guanine nucleotide exchange factors.

Authors:  I P Whitehead; R Khosravi-Far; H Kirk; G Trigo-Gonzalez; C J Der; R Kay
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

Review 8.  Inositol trisphosphate and diacylglycerol: two interacting second messengers.

Authors:  M J Berridge
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

9.  NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.

Authors:  R Q Cron; S R Bartz; A Clausell; S J Bort; S J Klebanoff; D B Lewis
Journal:  Clin Immunol       Date:  2000-03       Impact factor: 3.969

Review 10.  Reciprocal regulation of the nuclear factor of activated T cells and HIV-1.

Authors:  F Pessler; R Q Cron
Journal:  Genes Immun       Date:  2004-05       Impact factor: 2.676

View more
  11 in total

1.  GnRH regulation of Jun and Atf3 requires calcium, calcineurin, and NFAT.

Authors:  April K Binder; Jean C Grammer; Maria K Herndon; Julie D Stanton; John H Nilson
Journal:  Mol Endocrinol       Date:  2012-03-22

Review 2.  Rho'ing in and out of cells: viral interactions with Rho GTPase signaling.

Authors:  Céline Van den Broeke; Thary Jacob; Herman W Favoreel
Journal:  Small GTPases       Date:  2014-03-24

Review 3.  HIV persistence: chemokines and their signalling pathways.

Authors:  Vanessa A Evans; Gabriela Khoury; Suha Saleh; Paul U Cameron; Sharon R Lewin
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-28       Impact factor: 7.638

Review 4.  Function and regulation of microRNA-31 in development and disease.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Mol Reprod Dev       Date:  2016-08-02       Impact factor: 2.609

Review 5.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

Review 6.  MicroRNAs--novel regulators of systemic lupus erythematosus pathogenesis.

Authors:  Nan Shen; Dong Liang; Yuanjia Tang; Niek de Vries; Paul-Peter Tak
Journal:  Nat Rev Rheumatol       Date:  2012-10-16       Impact factor: 20.543

Review 7.  Transcriptional regulation of IL-2 in health and autoimmunity.

Authors:  José C Crispín; George C Tsokos
Journal:  Autoimmun Rev       Date:  2008-08-24       Impact factor: 9.754

8.  The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients.

Authors:  Khalda Sayed Amr; Faten S Bayoumi; Fatema T Elgengehy; Sanaa O Abdallah; Hanan H Ahmed; Eman Eissa
Journal:  Rheumatol Int       Date:  2016-08-10       Impact factor: 2.631

Review 9.  Control of Immunoregulatory Molecules by miRNAs in T Cell Activation.

Authors:  Ana Rodríguez-Galán; Lola Fernández-Messina; Francisco Sánchez-Madrid
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

Review 10.  MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis.

Authors:  Sheng Yan; Lok Yan Yim; Liwei Lu; Chak Sing Lau; Vera Sau-Fong Chan
Journal:  Immune Netw       Date:  2014-06-19       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.